|
| 36057777 | Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real-world healthcare databases. | Pharmacoepidemiol Drug Saf | 2023 |
| 37488783 | Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States. | J Viral Hepat | 2023 |
| 37751206 | Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy. | JAMA Netw Open | 2023 |
| 37895456 | Statistical Approaches to Identify Pairwise and High-Order Brain Functional Connectivity Signatures on a Single-Subject Basis. | Life (Basel) | 2023 |
| 37886466 | Oral Health Outcomes In An HIV Cohort With Comorbidities- Implementation Roadmap For A Longitudinal Prospective Observational Study. | Res Sq | 2023 |
| 37568531 | Telemedicine in Patients Affected by Chronic Liver Disease: A Scoping Review of Clinical Outcomes and the Devices Evaluated. | J Clin Med | 2023 |
| 36949300 | Tacrolimus-induced akinetic mutism and persistent dysarthria following orthotopic liver transplantation. | Neurol Sci | 2023 |
| 37414564 | Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants. | Neurology | 2023 |
| 37278688 | Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States. | Pharmacoepidemiol Drug Saf | 2023 |
| 37276449 | Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV. | Pharmacoepidemiol Drug Saf | 2023 |
| 37303490 | Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. | BMJ Med | 2023 |
| 37229695 | Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. | Clin Infect Dis | 2023 |
| 37227710 | Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many). | JAMA | 2023 |
| 37263775 | Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1â¿¿year: Where do we go from here? | Pharmacoepidemiol Drug Saf | 2023 |
| 37127082 | Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review. | Mech Ageing Dev | 2023 |
| 36480765 | Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019. | Am J Public Health | 2023 |
| 36786300 | Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications. | J Am Geriatr Soc | 2023 |
| 36719785 | European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. | Brain Connect | 2023 |
| 35324575 | Neurological Screening in Elderly Liver Transplantation Candidates: A Single Center Experience. | Neurol Int | 2022 |
| 35611675 | Profiling real-world data sources for pharmacoepidemiologic research: A call for papers. | Pharmacoepidemiol Drug Saf | 2022 |
| 35471704 | Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products. | Pharmacoepidemiol Drug Saf | 2022 |
| 35488097 | Brain magnetic resonance imaging radiomics features associated with hepatic encephalopathy in adult cirrhotic patients. | Neuroradiology | 2022 |
| 35848549 | Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy. | AIDS | 2022 |
| 37261208 | How to Improve Patients' Perceived Quality of Sleep During Hospitalization Through a Multicomponent "Good Sleep Bundle": A Prospective Before and After Controlled Study. | Glob J Qual Saf Healthc | 2022 |
| 36515952 | Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. | JAMA Netw Open | 2022 |
| 36573981 | COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply. | JAMA | 2022 |
| 35972486 | Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients. | JAMA | 2022 |
| 36303554 | Epigenome-wide association study of biomarkers of liver function identifies albumin-associated DNA methylation sites among male veterans with HIV. | Front Genet | 2022 |
| 36092829 | The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population. | Open Forum Infect Dis | 2022 |
| 36185993 | Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium. | Alzheimers Dement (N Y) | 2022 |
| 35283213 | Reply to: "Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with PI-based DAAs?" | J Hepatol | 2022 |
| 35202048 | Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV. | J Acquir Immune Defic Syndr | 2022 |
| 33422626 | National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. | J Am Acad Dermatol | 2021 |
| 33627360 | Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar. | BMJ Glob Health | 2021 |
| 33544904 | The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders. | Hepatology | 2021 |
| 33595662 | Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. | JAMA Netw Open | 2021 |
| 33533072 | Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system. | Pharmacoepidemiol Drug Saf | 2021 |
| 33780007 | Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America. | Hepatology | 2021 |
| 33885214 | Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies. | Pharmacoepidemiol Drug Saf | 2021 |
| 34870254 | Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study. | Lancet Healthy Longev | 2021 |
| 34610030 | The impact of disease-related knowledge on perceptions of stigma among patients with Hepatitis C Virus (HCV) infection. | PLoS One | 2021 |
| 34712041 | Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United States. | Drugs Ther Perspect | 2021 |
| 34185563 | The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders. | J Manag Care Spec Pharm | 2021 |
| 34296203 | Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study. | Lancet Healthy Longev | 2021 |
| 34144957 | Global covid-19 vaccine rollout and safety surveillance-how to keep pace. | BMJ | 2021 |
| 34170057 | Development and validation of case-finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data. | Pharmacoepidemiol Drug Saf | 2021 |
| 34333102 | Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation. | J Hepatol | 2021 |
| 33245789 | Drug-Drug Interaction Surveillance Study: Comparing Self-Controlled Designs in Five Empirical Examples in Real-World Data. | Clin Pharmacol Ther | 2021 |
| 31575557 | Differences in Pathology, Staging, and Treatment between HIV<sup>+</sup> and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 31938995 | Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection. | Dig Dis Sci | 2020 |